Skip to main content

Team Maureen


Vaccine News

Vaccine reduces HPV prevalence among teen girls by 86% in 10 years

Within 10 years of vaccine introduction, HPV prevalence decreased 86% among females aged 14 to 19 years in the United States, and 71% in women aged 20 to 24 years, according to study findings presented at the CDC’s Epidemic Intelligence Service, or EIS, conference.